Not finding it? Sign in to also search OpenAlex live.
-
Castration of Male Mice Induces Metabolic Remodeling of the Heart2022 Journal of the Endocrine Society article Medicine Hormonal and reproductive studies Open access
Elin Svedlund Eriksson, Anna K. F. Mårtensson, Marta Lantero Rodriguez, Maaike Schilperoort, Jan Kroon, Sander Kooijman, +5 more
5citations -
Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan2021 Japanese Journal of Clinical Oncology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Hiroyuki Okumura, Sachie Inoue, Shevani Naidoo, Stefan Holmström, Hideyuki Akaza
10citations -
PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients2024 European Journal of Radiology article Medicine Prostate Cancer Treatment and Research Open access
Fleur Kleiburg, Lioe‐Fee de Geus‐Oei, Saskia A. C. Luelmo, Jelle J. Goeman, Frits Smit, Tom van der Hulle, +1 more
22citations -
Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer2023 Frontiers in Nuclear Medicine article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Robin Gutsche, Gizem Gülmüs, Felix Manuel Mottaghy, Florian Gärtner, Markus Essler, Dirk von Mallek, +3 more
19citations -
A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE2021 International Journal of Cancer article Medicine Prostate Cancer Treatment and Research Open access
Heather Ann Payne, Angus Robinson, Bernard Rappe, Serena Hilman, Ugo De Giorgi, Steven Joniau, +13 more
18citations -
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
Maria De Santis, Sara Martínez Breijo, Paul J. Robinson, Camille Capone, Katie C Pascoe, Suzy Van Sanden, +6 more
10citations -
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with223Ra: PARABO, a Prospective, Noninterventional Study2023 Journal of Nuclear Medicine article Medicine Prostate Cancer Treatment and Research Open access
HOLGER PALMEDO, Hojjat Ahmadzadehfar, Susanne Martina Eschmann, Andreas Niesen, Johann Schönberger, Vahé Barsegian, +5 more
9citations -
An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer2021 Pharmacology Research & Perspectives article Medicine Prostate Cancer Treatment and Research Open access
Josephina P. M. Vrouwe, Ingrid M. C. Kamerling, Michiel Joost van Esdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van der Pluijm, +2 more
5citations -
Laying the groundwork for future health economic evaluation of [18F]PSMA PET/CT in guiding treatment decisions for metastatic castration-resistant prostate cancer patients2026 European Journal of Radiology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Sietse van Mossel, K.J.M. van der Velden, Fleur Kleiburg, T. van der Hulle, H. Koffijberg, M. C. P. Kuppen, +4 more
0citations -
A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [225Ac]Ac-FL-020, an anti-PSMA radioconjugate, in patients with metastatic castration-resistant prostate cancer (mCRPC).2025 Journal of Clinical Oncology conference-abstract Medicine Radiopharmaceutical Chemistry and Applications
Andrei H. Iagaru, GIUSEPPE T. CARDACI, Aaron Richard Hansen, Jeffrey Y.C. Wong, Carlos Artigas, Karolien E. Goffin, +7 more
0citations -
Pain response and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): Final results from a prospective, noninterventional study (PARABO)
HOLGER PALMEDO, Susanne Martina Eschmann, Andreas Niesen, Vahé Barsegian, Knut Liepe, Felix Manuel Mottaghy, +2 more
0citations -
2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: study results from a Dutch cohort
Kim J. M. van der Velden, Sietse van Mossel, Fleur Kleiburg, Lioe‐Fee de Geus‐Oei, Tom van der Hulle, Malou C. P. Kuppen, +3 more
0citations -
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials2021 Prostate Cancer and Prostatic Diseases article Medicine Prostate Cancer Treatment and Research Open access
Bertrand F. TOMBAL, Stephen J. Freedland, Andrew J. Armstrong, Tomasz M. Beer, Arnulf Stenzl, Cora Nanette Sternberg, +8 more
8citations